Interleukin-10 Protects against Ureteral Obstruction-Induced Kidney Fibrosis by Suppressing Endoplasmic Reticulum Stress and Apoptosis

• Published in: International journal of molecular sciences Vol. 23; no. 18; p. 10702
• Main Authors: Jung, Kyongjin, Lee, Taejin, Kim, Jooyoung, Sung, Eongi, Song, Inhwan
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 14-09-2022; MDPI
• Subjects: Apoptosis; Brefeldin A; Cytokines; Disease; End-stage renal disease; Endoplasmic reticulum; endoplasmic reticulum stress; Epithelial cells; Epithelium; Extracellular matrix; Fibrosis; Genes; Inflammation; Interleukin 10; Kidney diseases; Kidneys; Kinases; Pathophysiology; Phenylbutyric acid; Proteins; renal fibrosis; Sensors; siRNA; Thapsigargin; Transfection; Tunicamycin; unilateral ureteral obstruction
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms231810702

Fibrosis is a common final pathway of chronic kidney disease, which is a major incurable disease. Although fibrosis has an irreversible pathophysiology, the molecular and cellular mechanisms responsible remain unclear and no specific treatment is available to halt the progress of renal fibrosis. Thus, an improved understanding of the cellular mechanism involved and a novel therapeutic approach are urgently required for end-stage renal disease (ESRD). We investigated the role played by interleukin-10 (IL-10, a potent anti-inflammatory cytokine) in kidney fibrosis and the mechanisms involved using IL-10−/− mice and TCMK-1 cells (mouse kidney tubular epithelial cell line). Endoplasmic reticulum stress (ERS), apoptosis, and fibrosis in IL-10−/− mice were more severe than in IL-10+/+ mice after unilateral ureteral obstruction (UUO). The 4-Phenylbutyrate (an ERS inhibitor) treatment induced dramatic reductions in ERS, apoptosis, and fibrosis-associated factors in the renal tissues of IL-10−/− mice, compared to wild-type controls after UUO. On the other hand, in cultured TCMK-1 cells, the ERS inducers (tunicamycin, thapsigargin, or brefeldin A) enhanced the expressions of proapoptotic and profibrotic factors, though these effects were mitigated by IL-10. These results were supported by the observation that IL-10 siRNA transfection aggravated tunicamycin-induced CHOP and a-SMA expressions in TCMK-1 cells. We conclude that the anti-fibrotic effects of IL-10 were attributable to the inhibition of ERS-mediated apoptosis and believe that the results of this study improve the understanding of the cellular mechanism responsible for fibrosis and aid in the development of novel therapeutic approaches.